Find verified Dabigatran etexilate mesylate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Dabigatran etexilate mesylate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Dabigatran etexilate mesylate API.
Alternate Names: N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethy, Pradaxa mesylate
CAS No: 872728-81-9
PubChem CID: 135566083
Mol Formula: C35H45N7O8S
Mol Weight: 723.85 g/mol
IUPAC Name: ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acid
API Description: Dabigatran Etexilate Mesylate is an orally available mesylate salt form of the etexilate prodrug of dabigatran, a benzimidazole and direct thrombin inhibitor with anticoagulant activity. Upon administration, dabigatran etexilate is hydrolyzed by esterases and is converted into dabigatran. Dabigatran reversibly binds to and inhibits the activity of thrombin, a serine protease that converts fibrinogen into fibrin. This disrupts the coagulation cascade and inhibits the formation of blood clots.
